Literature DB >> 4104719

Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.

C C Bailey, C G Geary, M C Israëls, J A Whittaker, M J Brown, D J Weatherall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4104719     DOI： 10.1016/s0140-6736(71)91781-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Razoxane in treatment of acute myeloid leukaemia.

Authors:  M Bhavnani; K Dhir; I W Delamore
Journal:  Br Med J       Date:  1978-09-16

2.  Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside.

Authors:  T Büchner; B Barlogie; U Asseburg; W Hiddemann; D Kamanabroo; W Göhde
Journal:  Blut       Date:  1974-04

Review 3.  Advances in the management of adult acute myelogenous leukaemia.

Authors:  J A Whittaker
Journal:  Br Med J       Date:  1980-10-11

4.  Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.

Authors:  C B Freeman; R Harris; C G Geary; M J Leyland; J E MaCiver; I W Delamore
Journal:  Br Med J       Date:  1973-12-08

5.  Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.

Authors:  R Harris; S R Zuhrie; C B Freeman; G M Taylor; J E MacIver; C G Geary; I W Delamore; P J Hull; J A Tooth
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

6.  Adult acute leukaemia.

Authors:  K Atkinson; D G Wells; H M Clink; H E Kay; R Powles; T J McElwain
Journal:  Br J Cancer       Date:  1974-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.